First‐Line Therapy Option with Low‐Dose Bisoprolol Fumarate and Low‐Dose Hydrochlorothiazide in Patients with Stage I and Stage II Systemic Hypertension

The Journal of Clinical Pharmacology

Volumn 35, Issue 2, 1995, Pages 182-188

  Frishman, William H ^a   Burris, James F ^b   oczek, William J ^c   Weir, Matthew R ^d   Alemayehu, Demissie ^e   Simon, Joseph S ^e   Chen, Shun‐Yi ^e   Bryzinski, Brian S ^e  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Ovascular Center of Northern Virginia ^*  (United States)

^d UNIVERSITY OF MARYLAND MEDICAL CENTER   (United States)

^e PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BISOPROLOL FUMARATE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROCHLOROTHIAZIDE; PLACEBO;

ADULT; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BLOOD PRESSURE; BRADYCARDIA; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; FEMALE; HEART RATE; HUMAN; HYPERTENSION; HYPOKALEMIA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL;

AGED; BISOPROLOL; BLOOD PRESSURE; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; HYDROCHLOROTHIAZIDE; HYPERTENSION; MALE; MIDDLE AGED;

EID: 0028813939     PISSN: 00912700     EISSN: 15524604     Source Type: Journal    
DOI: 10.1002/j.1552-4604.1995.tb05009.x     Document Type: Article

References (13)

1. The Fifth Report of the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure (JNC V).
2. Multiple Risk Factor Intervention Trial: Risk factor changes and mortality results.
3. Which antihypertensive drugs first—and why!
4. Enalapril with either a ‘very low’ or ‘low’ dose of hydrochlorothiazide is equally effective in essential hypertension. A double‐blind trial in 100 hypertensive patients
5. Hypertension in elderly patients
6. A multifactorial trial design to assess combination therapy in hypertension: Treatment with bisoprolol and hydrochlorothiazide
7. Editorial review. Treating the individual hypertensive patient: Considerations of dose, sequential monotherapy and drug combinations
8. Cardiac factors in response to antihypertensive treatment
9. Which antihypertensive?
10. Combination of converting enzyme inhibitor with diuretic for the treatment of hypertension
11. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension.
12. Medical Research Council trial of treatment of hypertension in older adults: Principal results.
13. Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP‐Hypertension)